Trial Profile
An exploratory trial of Vacc 4x with a more convenient route of administration in HIV-1 infected patients
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 26 Mar 2018
Price :
$35
*
At a glance
- Drugs Vacc-4x (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Bionor Holding
- 29 Jan 2018 According to a Bionor media release, Bionor Pharma changed its name to Bionor Holding.
- 20 Jan 2016 New trial record